As gain of function mutations in KIT are present in 90% of adult mastocytosis patients and mutations in tyrosine kinase oncogenes can cause ROS accumulation [40], we examined whether mast cells carrying KIT mutations have abnormal ROS and DJ-1 levels reminiscent of patients with SM. Here, KIT is linked to systemic mastocytosis.